Drug Shortage Report for NUCYNTA EXTENDED-RELEASE

Last updated on 2019-12-19 History
Report ID 101052
Drug Identification Number 02415615
Brand name NUCYNTA EXTENDED-RELEASE
Common or Proper name TAPENTADOL
Company Name ENDO VENTURES LTD.
Market Status MARKETED
Active Ingredient(s) TAPENTADOL
Strength(s) 250MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 60 Tabs
ATC code N02AX
ATC description OPIOIDS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-12-11
Actual start date
Estimated end date 2019-12-31
Actual end date 2019-12-18
Shortage status Resolved
Updated date 2019-12-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD
BALLSBRIDGE, DUBLIN
IRELAND D04 H9P8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-12-11 English Compare
v2 2019-12-11 French Compare
v3 2019-12-12 English Compare
v4 2019-12-19 English Compare
v5 2019-12-19 French Compare

Showing 1 to 5 of 5